NVAX Tshuag Crashes Raws li Covid Kev Muag Tshuaj Tiv Thaiv, Nyiaj Lag Luam Kev Cia Siab

Novavax (NVAX) tau tshaj tawm cov muag muag muag thiab cov nyiaj tau los ntawm nws cov tshuaj tiv thaiv Covid-based protein rau hnub Monday, ua rau NVAX cov khoom lag luam poob.




X



Cov tshuaj tiv thaiv siv cov thev naus laus zis qub thiab tuaj yeem muab lwm txoj hauv kev rau cov neeg ntxhov siab txog cov tub txib tshiab RNA platforms siv los ntawm Pfizer (PFE) thiab Niaj hnub (mRNA). Tab sis thaum lub quarter thib peb, Novavax rub tsuas yog $ 704 lab, qhov kev kwv yees ploj los ntawm $ 141 lab.

Thawj thawj zaug, Novavax tau tshaj tawm cov txiaj ntsig. Lub tuam txhab khwv tau $ 2.66 ib feem, rho tawm qee yam khoom. Qhov ntawd tig los ntawm $ 3.05 ib qho kev poob qis hauv lub xyoo dhau los. Tab sis cov txiaj ntsig tsis pom kev kwv yees rau $ 2.69.

Tseem, nws tseem ceeb heev uas yuav tsum nco ntsoov qhov kev txhaj tshuaj Novavax tsis yog dav dav li Pfizer's thiab Moderna's. Nws tau tso cai rau kev siv thaum muaj xwm txheej ceev nyob rau hauv ib tug ob peb lub teb chaws, tab sis tsis yog lub US A committee ntawm Food and Drug Administration kws txawj npaj mus ntsib Lub rau hli ntuj 7 los tham txog Novavax txhaj.

Hauv qab-teev trading ntawm hnub no lub khw lag luam, NVAX khoom poob 9.9% ze ntawm 48. Shares poob 7.1% thaum lub sij hawm kev sib kho, xaus rau hnub ntawm 53.26.

NVAX Tshuag: Kev taw qhia rov hais dua

Novavax Tus Thawj Coj Stanley Erck tau sau tseg tias lub tuam txhab tau tshaj tawm nws cov tshuaj tiv thaiv thoob ntiaj teb. Nws tseem tab tom ua haujlwm nthuav dav kev tso cai rau menyuam yaus thiab vam tias yuav muaj kev txhaj tshuaj ntxiv.

"Qhov tseem ceeb, raws li kev hloov pauv tshiab tau tshwm sim, peb tau ua tiav peb lub tswv yim los npaj los daws qhov chaw muaj zog thiab txuas ntxiv kev txhim kho dhau Covid-19 nrog peb tus neeg sib tw tiv thaiv Covid-19-influenza," Erck tau hais hauv nqe lus sau.

Lub tuam txhab rov hais dua nws qhov kev cia siab rau $ 4 billion txog $ 5 billion hauv cov nyiaj tau los puv xyoo. Qhov nruab nrab ntawm qhov kev pom zoo yog nyob rau hauv txoj kab nrog NVAX cov kws tshuaj ntsuam xyuas kwv yees rau $ 4.49 billion. Cov kws tshuaj ntsuam kuj hu rau lub tuam txhab kom khwv tau $22.88 ib feem, rho tawm qee yam khoom.

Ua raws li Allison Gatlin ntawm Twitter ntawm @IBD_AGatlin.

KOJ UA LI CAS:

Seagen CEO Clay Siegall tau tso tseg tom qab muaj kev tsim txom hauv tsev

BioNTech Cov Nyiaj Tau Los Triples Ntawm Omicron Xav Tau Rau Nws Pfizer-Partnered Covid Txhaj Tshuaj

IBD Tshuag Ntawm Hnub: Saib Yuav Tsum Nrhiav Li Cas, Teev Thiab Yuav Cov Khoom Zoo

Saib IBD Cov Lus Qhia Txog Kev nqis peev qhia rau Kev Ua Lag Luam Kev Pom Zoo

IBD Digital: Txhim Kho IBD Daim Ntawv Teev Khoom Tseem Ceeb, Cov Cuab Yeej Thiab Cuam Tshuam Hnub no

Tau qhov twg los: https://www.investors.com/news/technology/nvax-stock-novavax-earnings-q1-2022/?src=A00220&yptr=yahoo